Age management medicine vs cardiometabolic optimization is a choice between two promises. Age management medicine promises to slow the clock, while cardiometabolic optimization promises to move the numbers that determine when you see a cardiologist and has the trials to back that promise. One field is built around an idea and the other around biomarkers that measurably respond to treatment. The distinction matters when you are deciding where several thousand dollars a year actually goes. We practice the second. This article explains why and is honest about what the first field does well.

Age management medicine grew out of anti-aging aesthetics and concierge longevity clinics: hormone pellets, peptide protocols, supplement stacks and imaging packages wrapped in a language of optimization and biological age. Some of it is legitimate clinical practice delivered generously. Some of it is monetized enthusiasm without evidence. The field is heterogeneous, which is exactly why a patient comparing it against cardiometabolic optimization deserves a real comparison rather than a brochure.

Key Takeaways
  • Age management medicine offers deep baselines and concierge access, but protocols like peptides and biological-age scores lack outcome evidence.
  • Cardiometabolic optimization treats insulin resistance, dyslipidemia, hypertension, hormonal decline and inflammation using randomized-trial-backed interventions.
  • The Cardiometabolic Optimization Membership is $299 a month with no tiers, beginning with a $598 first charge for the initial two-month commitment.
  • A quarterly Biomarker Audit is included and medication is billed separately at exact pharmacy cost with no markup.
  • Twelve months runs $3,588 and twenty-four months runs $7,176, versus $5,000 to $15,000 a year at concierge longevity clinics.
  • GoodLife Health does not offer peptides or hormone pellets and does not sell a biological age number.

The honest version of each field

What age management medicine does well: deep baselines, generous appointment time, aesthetic and vitality focus, attention to hormonal symptoms that conventional medicine dismisses and a concierge relationship model that many patients find worth paying for. Where it overlaps with board-certified endocrinology and legitimate hormone therapy, the care can be excellent.

What it does poorly: protocols that outrun evidence. Peptide regimens sold for recovery, skin or vitality lack human outcome data and sit in regulatory gray zones. Hormone pellets deliver a dose that cannot be adjusted after insertion, which we have critiqued elsewhere in detail. Biological age scores are interesting measurements dressed up as treatment targets and no trial has shown that lowering one extends life.

Clinical note

Hormone pellets deliver a dose that cannot be adjusted after insertion, which we have critiqued elsewhere in detail. We do not use them, because an implanted dose cannot be adjusted after insertion, which turns side-effect management into a removal procedure. We prefer titratable delivery monitored quarterly.

What cardiometabolic optimization does well: it treats the causal machinery of the diseases that actually shorten and disable lives, insulin resistance, dyslipidemia, hypertension, hormonal decline and chronic inflammation, using interventions with randomized-trial support, measured on a quarterly cadence, under continuous physician care.

What it is not: anti-aging aesthetics, a peptide clinic or a promise of longevity hacks. We will not sell you a biological age number, because the honest framing is risk reduction and function, not age reversal.

The evidence comparison, not the marketing comparison

Age Management Medicine vs. Cardiometabolic Optimization

The evidence comparison, not the marketing comparison

Intervention areaAge management medicine, typical protocolCardiometabolic optimization, evidence base
HormonesPellets or high-dose protocols, monitoring variesPhysiologic-dose therapy titrated against quarterly panels, guideline-anchored
Metabolic healthOften an afterthought to the hormone storyThe core system, with fasting insulin, HbA1c and glucose tracked every 90 days
LipidsFrequently limited to basic panelsApoB and Lp(a) measured and treated, statin and nonstatin therapy where indicated
WeightSometimes peptide or compounded GLP-1 protocolsBranded, FDA-approved GLP-1 therapy only, trial-anchored titration
PeptidesA revenue centerNot offered, because human outcome evidence does not support them
SupplementsExtensive protocols with marginTargeted repletion where labs show deficiency, no house-brand stacks

Read the peptide row carefully, because it is the clearest differentiator. Peptide commerce sells hope molecules with no human endpoint trials, often alongside the legitimate parts of a program. A practice that will sell you a peptide protocol for vitality will also have an incentive structure that profits from your continued subscription to optimism. We decline that business deliberately.

The two questions that separate medicine from aesthetics

When you evaluate any longevity practice, including ours, ask these:

  1. What would you measure to know this treatment is working and how often? A real answer names specific biomarkers and a cadence. An aesthetic answer names how you will feel.
  2. What is your protocol if the treatment needs to stop or reverse? Real medicine has exit ramps. Aesthetic protocols do not, because the exit ramp kills the subscription.

Our answers are public and structural. We measure a comprehensive Biomarker Audit every 90 days, included in the membership, reading ApoB, Lp(a), hs-CRP, HbA1c, lipids, fasting insulin and full hormone and thyroid panels. And de-escalation is built into the economics: the flat fee covers the doctor and the pharmacy charges you exactly what the medicine costs, with no markup and no dose-escalation fee, so the clinic has no revenue at stake in keeping you on anything.

GoodLife Health. Medicine that builds on itself, $299 a month: 90-day labs, your clinician, branded GLP-1s, one platform. See if you qualify.GoodLife Health. $299 a month. Everything talks to everything: quarterly labs read by your clinician, branded GLP-1s prescribed from them, every result and dose tracked on one platform. See if you qualify.

What the membership actually costs, against the concierge alternatives

The Cardiometabolic Optimization Membership is one flat $299 per month, no tiers. The first charge is $598, covering the initial two-month commitment, then $299 monthly, cancel anytime after. The quarterly Biomarker Audit is included. Medication is billed separately by the pharmacy at pharmacy cost with zero markup from us.

The math across a realistic tenure: twelve months costs $3,588. Twenty-four months costs $7,176, including eight comprehensive Biomarker Audits. A first year runs $3,289.

Compare that with concierge longevity clinics, which commonly charge $5,000 to $15,000 annually for memberships that may or may not include prescribing, with peptide and supplement programs billed separately. Hedge those figures as approximate, because they are, but the order of magnitude is the point: the price difference between concierge longevity medicine and our model funds years of care and the care we deliver is anchored to the biomarkers that trials have actually linked to outcomes.

What the membership costs
$299/mo
Cardiometabolic Optimization Membership, no tiers
$598
First charge, covering the initial two-month commitment
$3,588
Cost across twelve months
$7,176
Cost across twenty-four months, including eight Biomarker Audits
$5,000 to $15,000
Typical annual cost at concierge longevity clinics

Who each model genuinely fits

Age management medicine fits patients whose priority is vitality and aesthetics, who are comfortable with protocols whose evidence is thinner and who want an in-person concierge experience with generous access. That is a real product and some of it is good care.

Cardiometabolic optimization fits patients who want the opposite trade: fewer promises, more measurement, treatment anchored to randomized-trial evidence and a fee structure that cannot profit from their dose. If your goals include ApoB under 100, a fasting insulin in the single digits, hormone levels titrated to physiologic ranges and a physician who reads those numbers together every quarter, this is that model and it is what our cardiometabolic optimization program and hormone optimization pillars deliver in one membership.

The two models also combine well for some patients: a concierge longevity practice for imaging and depth, plus continuous cardiometabolic care for treatment. We support that hybrid without jealousy, because the treatment side is where outcomes are decided.

The price difference between concierge longevity medicine and our model funds years of care.

Frequently Asked Questions

What is age management medicine?

It is a clinical field focused on slowing age-related decline through hormone therapy, peptides, supplements and lifestyle protocols, usually delivered through concierge-style practices. Quality varies widely between clinics.

How is cardiometabolic optimization different?

It treats metabolic, hormonal and cardiovascular health as one system with trial-anchored interventions. Progress is measured quarterly through a comprehensive Biomarker Audit, without peptide protocols or biological-age marketing.

Is cardiometabolic optimization evidence based?

Yes. The interventions are statin and nonstatin lipid therapy, physiologic-dose hormone therapy, branded GLP-1 medication and structured lifestyle intervention. Each is anchored to randomized trials and guideline recommendations.

What does the Cardiometabolic Optimization Membership cost?

The membership is $299 a month with no tiers. The first charge is $598 and covers the initial two-month commitment. After that, it is $299 monthly and can be canceled anytime. The quarterly Biomarker Audit is included and the pharmacy bills medication separately at pharmacy cost with zero markup from us. Twelve months costs $3,588. Concierge longevity clinics commonly charge $5,000 to $15,000 a year.

Does GoodLife Health offer peptides or hormone pellets?

GoodLife Health offers neither. Peptides are not offered because human outcome evidence does not support them. Hormone pellets deliver a dose that cannot be adjusted after insertion, so we prefer titratable delivery monitored quarterly. GoodLife Health also does not sell a biological age number.

References

  1. Direct Primary Care: Practice Distribution and Cost Across the Nation (J Am Board Fam Med). 2015. pubmed.ncbi.nlm.nih.gov/26546651/